|
KMID : 0941820100200030221
|
|
Korean Journal of Clinical Pharmacy
2010 Volume.20 No. 3 p.221 ~ p.228
|
|
|
Development of Vancomycin Initial Dosage Guidelines to Achieve New Target Ranges
|
|
Yoo Jae-Young
Kim Jeong-Hyun
In Yong-Won
Kim Eun-Young
Sohn Kie-Ho
|
|
|
Abstract
|
|
|
|
In 2009, American Journal of Health-System Pharmacy (AJHP) recommended that targeting vancomycin trough concentrations of 10 mg/L or more because of therapeutic failure and potential risk of developing vancomycin resistance. Therefore, new dosage guidelines that could achieve to these higher target were needed. The aims of this study were to develop dosage guidelines targeting new vancomycin trough concentration and to evaluate the performance of these new guidelines. All data analysis were performed using NONMEM®. Population pharmacokinetic model was first developed from vancomycin dosage and concentration data collected retrospectively during routine therapeutic drug monitoring in 441 patients, then new vancomycin dosage guidelines were developed by using the model to predict vancomycin trough and peak concentrations in a simulated dataset. The estimates, such as, vancomycin concentration trough level, time to achieve target level, mean error were performed to evaluate and compare difference between conventional dosage and new dosage guidelines. The proposed dosage guidelines were predicted to achieve 43.5% of vancomycin trough level within 10~20 mg/L, which is significantly higher than current guidelines (26.3%). Time to achieve target trough level was 19.4 hours in new guidelines comparing to 93.1 hours in the conventional dosage. Thus, new vancomycin dosage guidelines have been developed to achieve new target trough concentrations earlier and more consistently than conventional guidelines.
|
|
|
KEYWORD
|
|
|
vancomycin, new target range, dosage guidelines
|
|
|
FullTexts / Linksout information
|
|
|
|
|
|
Listed journal information
|
|
|